Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT05042128 |
| Title | The ASCEND Study: Gemcitabine and Nab-Paclitaxel With CEND-1 or Placebo in Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma (ASCEND) |
| Acronym | ASCEND |
| Recruitment | Active, not recruiting |
| Gender | |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Australasian Gastro-Intestinal Trials Group |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | NZL | AUS |